INTRODUCTION {#h0.0}
============

*Streptococcus pneumoniae* is a Gram-positive diplococcus that can be carried asymptomatically in the nasopharynx of healthy individuals. The bacterium is also a significant pathogen and is the common causative agent of many community- and hospital-acquired infections, such as pneumonia and meningitis. In order to successfully colonize the nasopharynx in direct competition with other bacteria, including *Haemophilus influenzae*, *S. pneumoniae* routinely produces high levels of the oxidative stressor hydrogen peroxide ([@B1][@B2][@B3]). Increased levels of hydrogen peroxide have been directly correlated with enhanced cellular mistranslation rates in other microorganisms ([@B4], [@B5]). When taken together with the finding that pneumococci lack the four typical oxidative stress regulons of other bacteria (RpoS, OxyR, SoxRS, and Mar), it is unclear how this pathogen maintains translational fidelity during its normal life cycle ([@B6], [@B7]).

The aminoacyl-tRNA synthetases (aaRSs) establish and maintain the genetic code by specifically activating their cognate amino acid with ATP to form an aminoacyl-adenylate, which can then be transferred to the cognate tRNA acceptor molecule ([@B8], [@B9]). There are 20 aaRS enzymes in total and they correspond to the 20 standard amino acids present in the cell. Each aaRS is categorized as class I or class II, based on the overall structure and function, except for lysyl-tRNA synthetase (LysRS), which has representatives in both classes ([@B10][@B11][@B14]). Common features of class I aaRSs include a HIGH/KMSKS-motif-defined Rossmann nucleotide-binding fold at the active site, binding of the tRNA acceptor stem at the minor groove (with the exception of tyrosyl-tRNA synthetase), and aminoacylation of tRNA at the 2\'-hydroxyl group of the terminal adenine (A^76^) ([@B12], [@B15][@B16][@B17]). In contrast, class II aaRSs are characterized by a triple-motif antiparallel β-sheet fold at the active site, binding of the tRNA acceptor stem at the major groove, and aminoacylation of tRNA at the 3′ hydroxyl group of A^76^ (with the exception of phenylalanyl-tRNA synthetase) ([@B8]).

aaRSs provide the first step in quality control of translation. The degeneracy of the genetic code means that, in most cases, there are multiple tRNA isoacceptors specific for the same amino acid present within the cell. Accurate selection of cognate tRNA by the synthetase is typically achieved by a combination of specific identity elements in the tRNA molecule and also the large surface area available for binding and kinetic proofreading ([@B9], [@B18][@B19][@B20]). A more pressing challenge arises from the fact that some amino acids share close similarities in their chemical structures, which can make discrimination from noncognate amino acids particularly problematic. In the event that noncognate amino acids are recognized and activated, an intrinsic aaRS quality control mechanism exists that ensures such errors do not result in mistranslation of the genetic code. These quality control mechanisms clear noncognate amino acids both immediately following ATP-dependent activation (pretransfer editing) and/or following attachment to tRNA (posttransfer editing). For example, accurate discrimination against the isosteric amino acid Val by the class I IleRS involves posttransfer hydrolytic editing of Val-tRNA^Ile^, a reaction in which the D-loop of tRNA^Ile^ is particularly important ([@B21][@B22][@B24]). The *Escherichia coli* LysRS, a class II aaRS, has also been shown to have significant tRNA mischarging activity ([@B25]). In addition to generating Lys-tRNA^Lys^, *E. coli* LysRS was found to aminoacylate its cognate tRNA with Arg, Thr, Met, Leu, Ala, Ser, and Cys. Furthermore, the weak substrate specificity of the enzyme was exacerbated by a combination of inefficient pretransfer editing mechanisms for some amino acids and an entirely absent posttransfer editing mechanism.

Here we show that pneumococcal IleRS is able to robustly mischarge its cognate tRNA^Ile^ with Val and, surprisingly, Leu. However, the overall amino acid specificity of the enzyme is tRNA dependent and may be achieved without the need for editing under conditions when the cellular amino acid pool is balanced. Pneumococcal LysRS preferentially mischarges both isoacceptors of tRNA^Lys^ robustly with Ala, not Thr, and this likely provides an additional substrate for the Ala/Ser-aminoacyl-tRNA-dependent peptidoglycan biosynthesis enzyme MurM, which we have demonstrated to be a *trans*-editing factor in previous studies ([@B26], [@B27]). These findings support the hypothesis that broad-specificity tRNA mischarging spans both structural classes of the aminoacyl-tRNA synthetases in *S. pneumoniae* and provide insight into the mechanisms by which translational quality control has become adapted in this pathogen.

RESULTS {#h1}
=======

Pneumococcal LysRS mischarges both tRNA^Lys^ isoacceptors with multiple amino acids. {#h1.1}
------------------------------------------------------------------------------------

*E. coli* LysRS was previously found to catalyze the misaminoacylation of its cognate tRNA with several amino acids, including Ala ([@B25], [@B28]). In our earlier studies focusing on AlaRS, we demonstrated that mischarged Ala- and Ser-tRNA species can potentially enter the peptidoglycan biosynthesis pathway in *S. pneumoniae* via MurM ([@B27], [@B29]). We now investigated the capacity of pneumococcal LysRS to form mischarged Thr, Ala, and Ser tRNAs, the last two of which are also potential MurM substrates. Of the 3 amino acids tested in this study, mischarging by pneumococcal LysRS was greatest for Ala, regardless of the tRNA^Lys^ isoacceptor used ([Fig. 1A and C](#fig1){ref-type="fig"}). This preference of *S. pneumoniae* protein for Ala over Thr and Ser differs from *E. coli* LysRS, which uses Thr most efficiently ([@B25]). One possible reason for pneumococcal LysRS having a preference for Ala over Thr may be related to differences in the pneumococcal tRNA^Lys^ acceptor stem, most notably the presence of a U4:G69 wobble pair in place of the U4:A69 Watson-Crick base pair in *E. coli* tRNA^Lys^ ([Fig. 2](#fig2){ref-type="fig"}; see also [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Introduction of a Watson-Crick base pair (G69A) into each pneumococcal tRNA^Lys^ isoacceptor resulted in an approximately 3-fold increase in lysylation activity by LysRS compared to wild-type tRNAs ([Fig. 3](#fig3){ref-type="fig"}). The overall mischarging profile of pneumococcal LysRS remained the same with both the wild-type and the G69A tRNA^Lys^ transcripts; however, the yield of Ala-tRNA^Lys^ produced was increased by approximately 2-fold for the TTT G69A transcript and 3-fold for the CTT G69A transcript in comparison to the equivalent wild-type species ([Fig. 1B and D](#fig1){ref-type="fig"}; Ser-tRNA^Lys^ levels were too low to allow accurate determination of the effect of the G69A mutation \[data not shown\]). This suggests that, in the absence of efficient pre- and/or posttransfer editing mechanisms, the distorted region in the acceptor stem of tRNA^Lys^ is able to reduce the overall mischarging capacity of pneumococcal LysRS, with an accompanying loss in cognate charging.

![*S. pneumoniae* LysRS catalyzed mischarging of wild-type or G69A tRNA^Lys^ anticodon TTT (A and B, respectively) or CTT (C and D, respectively) with alanine, serine and threonine. Aminoacylation time courses were carried out in the presence of 250 µM \[^3^H\]-[l]{.smallcaps}-Ala, \[^3^H\]-[l]{.smallcaps}-Ser or \[^14^C\]-[l]{.smallcaps}-Thr. Each reaction mixture contained 4 µM active pneumococcal LysRS. Wild-type or G69A *S. pneumoniae* tRNA^Lys^ (anticodon CTT or TTT) was used at a concentration of 7 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810001){#fig1}

![Predicted cloverleaf structures of *S. pneumoniae* (A) and *E. coli* (B) tRNA^Lys^ anticodon TTT. Sequence variations from the *S. pneumoniae* tRNA^Lys^ sequence are highlighted in red. All tRNA cloverleaf structures are shown without the CCA end.](mbo0051419810002){#fig2}

![*S. pneumoniae* LysRS catalyzed Lys-tRNA^Lys^ formation. The aminoacylation time course in the presence of 40 µM [l]{.smallcaps}-\[^14^C\]Lys for 3.7 µM active pneumococcal LysRS is shown. Wild-type or G69A pneumococcal tRNA^Lys^ (anticodon CTT or TTT) was used at a concentration of 7 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810003){#fig3}

Generation of Ala-tRNA^Lys^ by pneumococcal LysRS may provide an additional substrate for peptidoglycan cross-linking by MurM. {#h1.2}
------------------------------------------------------------------------------------------------------------------------------

The relative instability of wild-type Ala-tRNA^Lys^ in solution (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material) compared to previously studied mischarged pneumococcal tRNAs ([@B27]) resulted in an inability to isolate sufficient quantities of this product for use in direct deacylation assays. Therefore, the effect of MurM addition on the ability of pneumococcal LysRS to produce mischarged Ala-tRNA^Lys^ was investigated. MurM reduced the mischarging capacity of pneumococcal LysRS in the presence of Ala regardless of the isoacceptor of tRNA^Lys^ present in the reaction mixture ([Fig. 4](#fig4){ref-type="fig"}). Our earlier studies with Ser-tRNA^Ala^ showed that reduction in the yield of this product by AlaRS upon addition of MurM was correlated with the *trans*-editing activity of the latter protein ([@B27]). In addition, the use of mischarged Ser-tRNA^Ala^ by MurM in peptidoglycan biosynthesis has already been demonstrated ([@B29]); therefore, it is likely that production of Ala-tRNA^Lys^ by LysRS provides another substrate that can be diverted from protein synthesis into this pathway.

![MurM decreases production of alanylated tRNA^Lys^ anticodons CTT (A) and TTT (B) by LysRS. Misaminoacylation time courses for generation of \[^3^H\]Ala-tRNA^Lys^ by 2 µM active pneumococcal LysRS in the presence of 0.6 µM MurM are shown. The concentration of wild-type pneumococcal tRNA^Lys^ used was 7 µM. The concentration of \[^3^H\]Ala used was 250 µM. Data sets are the averages of three independent experiments. Error bars indicate standard errors.](mbo0051419810004){#fig4}

The presence of the U4:G69 wobble pair in the acceptor stems of both tRNA^Lys^ isoacceptors raised the question of whether these species could be substrates for the pneumococcal AlaRS enzyme, as previously demonstrated for tRNA^Phe^ ([@B27]). Full-length pneumococcal AlaRS preferentially mischarged both wild-type tRNA^Lys^ transcripts with Ser over cognate Ala ([Fig. 5A and C](#fig5){ref-type="fig"}). The mutated G69A transcripts were also aminoacylated by full-length AlaRS, although slightly less efficiently in the case of the anticodon CTT transcript ([Fig. 5B and D](#fig5){ref-type="fig"}).

![Comparative *S. pneumoniae* full-length AlaRS-catalyzed mischarging of wild-type or G69A tRNA^Lys^ anticodon TTT (A and B, respectively) or CTT (C and D, respectively) with alanine and serine. Aminoacylation time courses were carried out in the presence of 250 µM [l]{.smallcaps}-\[^3^H\]Ala or [l]{.smallcaps}-\[^3^H\]Ser. Each reaction mixture contained 0.5 µM active full-length pneumococcal AlaRS. Wild-type or G69A *S. pneumoniae* tRNA^Lys^ (anticodon CTT or TTT) was used at a concentration of 7 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810005){#fig5}

Pneumococcal IleRS robustly mischarges its cognate tRNA with Leu and Val. {#h1.3}
-------------------------------------------------------------------------

Taken together with results of previous studies, the above findings now show extensive mischarging by *S. pneumoniae* class II-type aaRSs. To investigate if similar activities are found for class I-type aaRSs, the substrate specificity of IleRS during amino acid activation and aminoacylation was investigated. In the case of *E. coli* IleRS, the primary potential noncognate substrate is Val, which is effectively dealt with by a combination of pretransfer editing of Val-AMP and posttransfer editing of Val-tRNA^lle^ ([@B21], [@B23], [@B30]). Consequently, *E. coli* IleRS does not accumulate Val-tRNA^lle^ to levels expected to affect the overall error rate of translation. The abilities of pneumococcal and *E. coli* IleRS to mischarge cognate tRNA with both [l]{.smallcaps}-Leu and [l]{.smallcaps}-Val were compared. Pneumococcal IleRS was able to mischarge tRNA^Ile^ with Leu to approximately 5-fold-higher levels than the *E. coli* enzyme *in vitro* ([Fig. 6A](#fig6){ref-type="fig"}). Val-tRNA^Ile^ was also synthesized to higher levels by pneumococcal IleRS than by *E. coli* IleRS, although the difference was less significant than that observed with Leu ([Fig. 6B](#fig6){ref-type="fig"}).

![Comparative *S. pneumoniae* and *E. coli* IleRS-catalyzed mischarging of cognate tRNA^Ile^ with leucine (A) or valine (B). Aminoacylation time courses were evaluated in the presence of 200 µM [l]{.smallcaps}-\[^14^C\]Leu (A) or 200 µM [l]{.smallcaps}-\[^14^C\]Val (B) for 1 µM active pneumococcal or *E. coli* IleRS. Wild-type pneumococcal or *E. coli* tRNA^Ile^ (anticodon GAT) was used at a concentration of 10 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810006){#fig6}

To investigate if differences in mischarging between pneumococcal and *E. coli* IleRS result from variations in tRNA sequence (see [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material), noncognate aminoacylation experiments were performed. Replacement of *E. coli* tRNA^Ile^ with the *S. pneumoniae* tRNA^Ile^ did not significantly increase yields of Leu- or Val-tRNA^Ile^ produced by the *E. coli* IleRS enzyme ([Fig. 7A and B](#fig7){ref-type="fig"}, respectively). Further examination of the possible role of tRNA^Ile^ in amino acid specificity was investigated by using a G16C mutation in pneumococcal tRNA^Ile^, as this residue has been implicated in the editing of Val-tRNA^Ile^ by IleRS ([@B24], [@B31]). The aminoacylation capacity of pneumococcal IleRS was reduced by almost 50% for tRNA^Ile^ G16C compared to wild-type tRNA with both Ile ([Fig. 8A](#fig8){ref-type="fig"}) and Leu ([Fig. 8B](#fig8){ref-type="fig"}). However, no difference was seen for Val mischarging between the wild-type and the G16C transcript ([Fig. 8C](#fig8){ref-type="fig"}).

![Comparative *S. pneumoniae* and *E. coli* IleRS-catalyzed mischarging of pneumococcal tRNA^Ile^ with leucine or valine. Aminoacylation time courses were evaluated in the presence of 200 µM [l]{.smallcaps}-\[^14^C\]Leu (A) or 200 µM [l]{.smallcaps}-\[^14^C\]Val (B) for 1 µM active pneumococcal of *E. coli* IleRS. Wild-type pneumococcal tRNA^Ile^ (anticodon GAT) was used at a concentration of 10 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810007){#fig7}

![Comparative *S. pneumoniae* IleRS-catalyzed mischarging of wild-type and G16C tRNA^Ile^ with isoleucine (A), leucine (B), or valine (C). For the cognate amino acid, aminoacylation time courses were carried out in the presence of 22 µM [l]{.smallcaps}-\[^14^C\]Ile and 500 nM active pneumococcal IleRS (A). For the noncognate amino acids, aminoacylation time courses were carried out in the presence of 200 µM [l]{.smallcaps}-\[^14^C\]Leu or [l]{.smallcaps}-\[^14^C\]Val for 1 µM active pneumococcal IleRS. Wild-type or G16C pneumococcal tRNA^Ile^ (anticodon GAT) was used at a concentration of 10 µM. The presented data set is the average of three independent experiments. Error bars show standard errors.](mbo0051419810008){#fig8}

IleRS has weak posttransfer editing activity against Leu-tRNA^Ile^. {#h1.4}
-------------------------------------------------------------------

The robust level of mischarging seen with pneumococcal IleRS and Leu allowed aminoacylation kinetic parameters to be determined for tRNA^Ile^ ([Table 1](#tab1){ref-type="table"}). The comparatively low *k*~cat~ values derived in this study are likely due to the absence of the *N*-6-threonylcarbamoyl modification of adenine-37 in the anticodon loop of *in vitro*-transcribed tRNA^Ile^, as previously described in other systems ([@B22], [@B31], [@B32]). Pneumococcal IleRS has a *K*~M~ for Leu that is \~8,000-fold higher and a *k*~cat~ almost 3-fold higher than that for cognate Ile. Consequently, the catalytic efficiency of pneumococcal IleRS is approximately 2,850 times greater for Ile than Leu, giving a specificity constant comparable to overall error rates in protein synthesis which are generally estimated to be in the range of 1 in 3,000 to 10,000 ([@B33]). Specificity constants of less than 1 in 3,000 are typically associated with the lack of a requirement for editing among aminoacyl-tRNA synthetases under conditions that favor maintenance of a balanced intracellular amino acid pool ([@B34]). Therefore, the editing capacity of pneumococcal IleRS against Leu-tRNA^Ile^ was tested ([Fig. 9](#fig9){ref-type="fig"}). Both pneumococcal and *E. coli* IleRS were demonstrated to have relatively weak posttransfer editing activities, consistent with the specificity constant obtained from our kinetic studies.

###### 

Kinetic parameters for aminoacylation of tRNA^Ile^ with Ile and Leu by pneumococcal IleRS^[a](#ngtab1.1)^

  Amino acid   *K*~*m*~ (μM)   *V*~max~ (μM/min/mg)   *k*~cat~ (min^−1^)   *k*~cat~/*K*~*m*~   Specificity constant
  ------------ --------------- ---------------------- -------------------- ------------------- ----------------------
  Ile          0.4 ± 0.1       0.0005 ± 0.0002        0.06 ± 0.02          0.14                1:2,850
  Leu          3,200 ± 290     0.0015 ± 0.0002        0.16 ± 0.02          0.000049            

Means and standard errors are shown. *V*~max~ and *k*~cat~ values were determined using protein concentration estimations obtained via the Bradford assay.

![Deacylation of mischarged pneumococcal Leu-tRNA^Ile^ by *S. pneumoniae* and *E. coli* IleRS. Deacylation time courses were carried out as described above by incubation of 50 pM \[^14^C\]Leu-tRNA^Ile^ with 0.5 µM pneumococcal (A) or *E. coli* (B) IleRS. For the control reaction mixture, an equal volume of protein storage buffer was added. Error bars indicate standard errors.](mbo0051419810009){#fig9}

DISCUSSION {#h2}
==========

Pneumococcal IleRS retains fidelity without editing under conditions where the amino acid pool is balanced. {#h2.1}
-----------------------------------------------------------------------------------------------------------

Pneumococcal IleRS was found to mischarge tRNA^Ile^ with Leu significantly more efficiently than the *E. coli* enzyme misaminoacylated tRNA^Ile^ with Val. Despite this significant mischarging activity, pneumococcal IleRS maintains a substrate specificity for Ile over Leu that is consistent with reported error rates of translation. This is achieved in the absence of efficient editing by virtue of a 2,850-fold difference in catalytic efficiencies that ultimately favors turnover of cognate Ile over noncognate Leu ([Table 1](#tab1){ref-type="table"}). Nevertheless, conditions causing an imbalance of the cellular amino acid pool might be expected to result in increased mistranslation rates at Ile codons within this bacterium. In *S. pneumoniae* it is possible that both oxidative stress, caused by high-level hydrogen peroxide production, and the infection process itself may cause amino acid pool imbalances. Production of hydrogen peroxide by pneumococcus results in an alpha-hemolytic appearance on blood agar due to partial lysis of erythrocytes, and the pneumolysin toxin produced during host infection can cause full lysis of blood cells and other cells ([@B35], [@B36]). Therefore, serum is an expected source of amino acids for the bacterium during human infection. Plasma levels of Ile, Val, and Leu in humans are known to decrease during infection, with Leu remaining the most abundant postinoculation with *S. pneumoniae* in some instances ([@B37][@B38][@B39]). It has also been demonstrated for the intraerythrocytic protozoan malaria parasite *Plasmodium falciparum* that Ile becomes the limiting amino acid in the human host during infection. This is because Ile is absent from adult hemoglobin, which is the main source of nutrients for the parasite ([@B40], [@B41]). The relative abundance of Leu and the absence of an efficient editing mechanism may have allowed pneumococcal IleRS to evolve so that it remains functional, regardless of the severity and duration of host infection, even under conditions of limited availability of the cognate amino acid Ile.

Pneumococcal tRNA^Lys^ has evolved to function in both protein and peptidoglycan biosynthesis. {#h2.2}
----------------------------------------------------------------------------------------------

Our findings demonstrate that like *E. coli*, pneumococcal LysRS has relaxed amino acid substrate specificity, although in this case Ala rather than Thr is the preferred substrate for tRNA^Lys^ mischarging. This difference in noncognate amino acid specificity is accompanied by significant changes in the structure of both tRNA^Lys^ isoacceptors, namely, the presence of an unusual wobble pair (U4:G69) reminiscent of the G3:U70 pair critical for recognition of tRNA^Ala^ by AlaRS ([@B18], [@B42][@B43][@B45]). The presence of this wobble region in the acceptor stem of pneumococcal tRNA^Lys^ controls the efficiency of tRNA aminoacylation by LysRS and to a lesser extent that by AlaRS. Replacement of the wobble region with a correct Watson-Crick base pair (mutant tRNA^Lys^ G69A) resulted in improved aminoacylation by LysRS, suggesting that the wobble pair has been specifically selected for and retained during evolution, although the underlying selection pressure remains unclear. A similar improvement in isoacceptor aminoacylation capacity was demonstrated for phenylalanylation of tRNA^Phe^ U4G by pneumococcal PheRS in comparison to that by the wild-type species ([@B27]). In addition, our studies have demonstrated that the presence of the aminoacyl-tRNA-dependent peptidoglycan cross-linking enzyme, MurM, lowers the yield of Ala-tRNA^Lys^ produced by pneumococcal LysRS. This supports our earlier finding that MurM can also act as a *trans*-editing factor by effectively directing both mischarged Ala and Ser species away from protein synthesis and into peptidoglycan biosynthesis ([@B27]).

The identification of an unusual wobble region in the acceptor stems of both tRNA^Phe^ and tRNA^Lys^ suggests that pneumococcus may have evolved to have a specific subset of its tRNA species accessible to both pathways. This is in contrast to the mechanism by which *Staphylococcus aureus* is known to ensure adequate provision of Gly-tRNA^Gly^ for cell wall cross-linking and protein synthesis. In *S. aureus*, peptidoglycan is indirectly cross-linked by virtue of a pentaglycine bridge that is formed by the activity of the glycyl-tRNA-dependent FemXAB proteins ([@B46]). It has been established that there are four fully annotated tRNA^Gly^ isoacceptors encoded in the genome of this bacterium plus a fifth pseudogene that encodes an unusual Gly isoacceptor. All five isoacceptors are efficiently aminoacylated by glycyl-tRNA synthetase; however, three of them contain sequence-specific identity elements that are consistent with weak EF-Tu binding and are, therefore, likely to be specifically shuttled into the peptidoglycan biosynthesis pathway ([@B47]). In pneumococcus, peptidoglycan is indirectly cross-linked by the addition of Ala-Ala or Ser-Ala dipeptide bridges. The MurM and MurN proteins specifically catalyze dipeptide bridge formation by using Ala and/or Ser tRNA species originally thought to be provided selectively by alanyl- and seryl-tRNA synthetase, respectively ([@B48][@B49][@B50]). However, no unique tRNA^Ala^ or tRNA^Ser^ isoacceptors have been identified in this bacterium. As a result, the mechanism by which pneumococcus ensures adequate provision of substrates for both protein and peptidoglycan biosynthesis has remained elusive. Our studies demonstrate that the mechanism used by pneumococcus may reside in the unique evolutionary modification of a specific subset of tRNAs within the cell which subsequently alters the substrate specificity of the aminoacyl-tRNA synthetases.

Broad-specificity tRNA mischarging occurs across both classes of tRNA synthetase in *S. pneumoniae*. {#h2.3}
----------------------------------------------------------------------------------------------------

The translation quality control systems of *S. pneumoniae* are somewhat unique in terms of both the mischarging and editing profiles of the corresponding aaRSs and the absence of *trans-*editing factors such as AlaXp and Ybak, commonly found in other bacteria ([@B27]). For the class I enzyme IleRS, elevated mischarging activity offers a potential mechanism for adaptive translation during cognate amino acid limitation ([@B51]). For the class II enzymes AlaRS, LysRS, and PheRS, the ability to generate and/or protect a broad range of Ala and Ser mischarged tRNA offers a versatile mechanism to provide substrates for peptidoglycan biosynthesis. Further studies are now warranted to explore *in vivo* the apparently widespread role of aaRS-catalyzed misaminoacylation in *S. pneumoniae*. In addition to aaRS-specific adaptations, pneumococcus is also known to have a unique EF-Tu protein that differs in sequence from that of other bacteria at four positions: P129K, M140L, T230S, and E234D ([@B52]). All of these adaptations may have, in part, been driven by evolutionary pressure for the bacterium to adapt to its unusual lifestyle. It is well documented that pneumococcus routinely produces and, therefore, exposes itself to high levels of hydrogen peroxide during its natural life cycle as a means of competing with other bacterial species for colonization of the nasopharynx ([@B3]). Further characterization of aaRS-specific and other types of adaptations that pneumococcus has made to maintain quality control of translation while ensuring adequate provision of aminoacylated tRNA substrates for both peptidoglycan and protein synthesis may enable identification of new drugs targets in the future.

MATERIALS AND METHODS {#h3}
=====================

Strains, plasmids, and general protein expression and purification. {#h3.1}
-------------------------------------------------------------------

*S. pneumoniae* strain D39 chromosomal DNAs for use as a template in the cloning of genes encoding IleRS, LysRS, EF-Tu, AlaRS, and MurM were a gift from B. Lazazzera (University of California, Los Angeles). *E. coli ileS* was cloned by amplification of the gene from strain BL21(DE3) by colony PCR. The gene encoding *S. pneumoniae ileS* was cloned into pQE-31 (Qiagen) by virtue of the BamHI and HindIII restriction sites. The subsequent expression construct allowed for the production of a recombinant protein extended at the N terminus by a six-histidine tag. The genes encoding *E. coli* IleRS, *S. pneumoniae* AlaRS, and *S. pneumoniae* MurM were cloned into pET21b (Novagen) by virtue of the NdeI and XhoI restriction sites, allowing for the production of recombinant protein extended at the C terminus by a six-histidine tag. All cloned expression constructs were checked for accuracy against the appropriate protein sequences found in the comprehensive microbial resource database (J. Craig Venter Institute) by Sanger DNA sequencing (Plant Microbial Genomics Facility, The Ohio State University) with the appropriate primers. Both IleRS proteins were overexpressed in *E. coli* strain B834(DE3) by the addition of a final concentration of 1 mM isopropyl-β-[d]{.smallcaps}-1-thigalactopyranoside at an optical density at 600 nm (OD~600~) of 0.4 followed by a reduction in growth temperature from 37°C to 25°C for 3 to 5 h. EF-Tu and MurM were overexpressed in the same way; however, the expression strain was changed to *E. coli* BL21(DE3). Proteins were purified on BD Talon cobalt resin using equilibration/wash buffer (50 mM sodium phosphate \[pH 7.2\], 500 mM sodium chloride, and 20% glycerol) containing 250 mM imidazole. MurM was solubilized prior to purification as described elsewhere ([@B29]). *S. pneumoniae* tRNA^Ile^, *E. coli* tRNA^Ile^, and *S. pneumoniae* tRNA^Lys^ (anticodons CTT and TTT) were produced by *in vitro* T~7~ RNA polymerase runoff transcription as described previously ([@B53], [@B54]).

Determination of protein concentration by active site titration or Bradford assay. {#h3.2}
----------------------------------------------------------------------------------

To determine active protein concentrations for IleRS, AlaRS, and LysRS, 5 µl of undiluted protein or protein diluted 1:10 or 1:20 was incubated in three separate reaction mixtures for 10 min at 37°C in the presence of 0.1 M Na-HEPES (pH 7.2), 30 mM KCl, 10 mM MgCl~2~, 2 mM ATP, 2 µmol min^−1^ ml^−1^ inorganic pyrophosphatase (Roche), and 40 µM cognate amino acid (\[^14^C\]Lys, \[^3^H\]Ala, or \[^14^C\]Ile from PerkinElmer or Moravek Biochemicals). A control reaction was also carried out where the reaction volume of protein was replaced by protein storage buffer. Samples were processed by vacuum filtration onto Whatman Protran BA85 filter paper circles. After sample spotting, each filter paper was washed three times with buffer comprised of 50 mM Na-HEPES (pH 7.2), 15 mM KCl, 5 mM MgCl~2~ prior to drying and quantification by liquid scintillation counting ([@B55]). For determination of protein concentration by the Bradford assay, Bradford reagent was obtained from Bio-Rad and used as per the manufacturer's instructions. A standard curve with known concentrations of bovine serum albumin (resuspended in IleRS storage buffer) was obtained to improve accuracy of estimations.

Aminoacylation. {#h3.3}
---------------

Aminoacylation time courses were carried out over a time period of 1 h at 37°C in the presence of 0.1 M Na-HEPES (pH 7.2), 30 mM KCl, 10 mM MgCl~2~, 2 mM ATP, 2 µmol min^−1^ ml^−1^ inorganic pyrophosphatase (Roche), 10 µM tRNA^Ile^ or tRNA^Lys^ transcript, 20 to 40 µM cognate amino acid (\[^14^C\]Lys or \[^14^C\]Ile from PerkinElmer or Moravek Biochemicals, respectively) or 200 µM noncognate amino acid (\[^3^H\]Ser, \[^14^C\]Thr, \[^3^H\]Ala, \[^14^C\]Leu, or \[^14^C\]Val) at 150 to 500 cpm/pmol and 0.5 to 4.0 µM active IleRS, AlaRS, or LysRS (as determined by active site titration). Where appropriate, reactions were repeated in the presence of 500 nM *S. pneumoniae* MurM. Ten-microliter samples were taken for each time point and spotted onto 3-mm Whatman filter paper discs, which were immediately dropped into 5% trichloroacetic acid (TCA). Discs were subjected to two further washes with 5% TCA and ethanol prior to drying and scintillation counting.

Kinetics of isoleucylation and leucylation of tRNA^Ile^ by pneumococcal IleRS. {#h3.4}
------------------------------------------------------------------------------

To determine the steady-state kinetic parameters for pneumococcal IleRS with either [l]{.smallcaps}-Ile or [l]{.smallcaps}-Leu, aminoacylation time courses were carried out at 37°C for both the lowest (1.5 µM Ile and 30 µM Leu) and the highest (50 µM Ile and 1 mM Leu) amino acid concentrations in the presence of 0.1 M Na-HEPES (pH 7.2), 30 mM KCl, 10 mM MgCl~2~, 2 mM ATP, 2 µmol min^−1^ ml^−1^ inorganic pyrophosphatase (Roche), 10 µM pneumococcal tRNA^Ile^ transcript, and 500 nM or 1 µM active IleRS for Ile and Leu, respectively (as determined by active site titration). For Ile, the linear region was determined to be within the first 5 min; therefore, 10-µl samples were spotted onto 3-mm Whatman filter paper and dropped into 5% TCA at four time points (1, 2, 3, and 5 min) at each of the amino acid concentrations (1.5, 3, 5, 8, 10, 15, 20, 30, 40, and 50 µM) for determination of gradients and key kinetic parameters from triplicate data sets, using the Hanes-Woolf method. For Leu, the linear region was determined to be within the first 30 min; therefore, 10-µl samples were spotted onto 3-mm Whatman filter paper and dropped into 5% TCA at four time points (10, 15, 20, and 30 min) at each of the amino acid concentrations (30, 50, 100, 200, 250, 300, 400, 500, 600, and 1,000 µM) for determination of gradients and key kinetic parameters from triplicate data sets, using the Michaelis-Menten analysis method in Prism software (GraphPad).

Deacylation assays. {#h3.5}
-------------------

Aminoacylation reactions were set up in four 200-µl reaction mixtures, each consisting of 30 mM HEPES (pH 7.6), 15 mM MgCl~2~, 10 mM diethiothreitol, 2 mM ATP, 2 µmol min^−1^ ml^−1^ inorganic pyrophosphatase (Roche), 250 µM \[^14^C\]Leu (with a specific activity of \~300 cpm/pmol), 10 µM *S. pneumoniae* tRNA^Ile^ transcript (prior to use, stock was resuspended in 2 mM MgCl~2~ and heated at 80°C for 10 min, followed by slow cooling to room temperature to allow refolding), 2 µM mol min-^1^ ml^−1^ inorganic pyrophosphatase, and 1 µM IleRS. The reaction mixtures were incubated at 37°C for 1 h, quenched with 20 µM of 3 M sodium acetate (pH 4.5), and processed as described elsewhere ([@B27]). Deacylation assays were carried out by incubation of 50 pM \[^14^C\]Leu-tRNA^Ile^ in buffer composed of 0.1 M Na-HEPES (pH 7.2), 30 mM KCl, and 10 mM MgCl~2~. In addition, 0.5 µM *E. coli* or *S. pneumoniae* IleRS, 0.5 µM MurM, or an equal volume of protein storage buffer was added to the reaction mixtures, which were monitored by TCA precipitation and scintillation counting. Attempts to utilize pneumococcal Val-tRNA^Ile^ for deacylation assays were not successful due to rapid spontaneous deacylation during isolation.

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

Predicted cloverleaf structures of *S. pneumoniae* tRNA^Lys^ anticodons TTT (A) and CTT (B). Sequence variations between the two tRNA^Lys^ isoacceptors are highlighted in red. All tRNA cloverleaf structures are shown without the CCA end. Download

###### 

Figure S1, PDF file, 0.1 MB

###### 

Natural deacylation of mischarged pneumococcal Ala-tRNA^Lys^ demonstrates its inherent instability. Deacylation time courses were carried out as described in the text with incubation of 10 pM \[^14^C\]Ala-tRNA~Lys~ in buffer composed of 0.1 M Na-HEPES (pH 7.2), 30 mM KCl, and 10 mM MgCl~2~. Download

###### 

Figure S2, PDF file, 0.1 MB

###### 

Predicted cloverleaf structures of *E. coli* (A) and *S. pneumoniae* (B) tRNA^Ile^ (anticodon GAU). Sequence variations from the *S. pneumoniae* tRNA^Ile^ sequence are highlighted in red. All tRNA cloverleaf structures are shown without the CCA end. Position 16 is boxed. Download

###### 

Figure S3, PDF file, 0.1 MB
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